Basic & Clinical Medicine ›› 2017, Vol. 37 ›› Issue (2): 261-264.

Previous Articles     Next Articles

Research progress of thrombin activatiable fibrinolysis inhibitor in cardiovascular and cerebrovascular diseases

  

  • Received:2016-03-24 Revised:2016-05-26 Online:2017-02-05 Published:2017-01-16
  • Supported by:
    the National Natural Science Foundation of China;the National Natural Science Foundation of China;the National Natural Science Foundation of China

Abstract: Thrombin activatable fibrinolysis inhibitor (TAFI) is a kind of plasma enzymes that can be activated by thrombin. TAFI regulates blood coagulation and fibrinolysis and has a strong fibrinolytic and anti-inflammatory activity. Its inhibitor is expected to avoid the risk of bleeding when thrombolytic recanalization. Also, studies found that TAFI played an important role in the development of cerebral thrombosis; atherosclerosis and so on.

Key words: thrombin activation of fibrinolysis inhibitor (TAFI), cerebral thrombosis, cardiovascular disease

CLC Number: